Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
ore-1001 | angiotensin-converting enzyme 2 | NA | Clinical trial target | TTD , DGIDB | Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
47.74 | phase 1/2 | unknown |
ore-1001 | carboxypeptidase n catalytic chain | small molecule | NA | drugbank | Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
NA | investigational | unknown |
ore-1001 | carboxypeptidase n subunit 2 | small molecule | NA | drugbank | Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
NA | investigational | unknown |
click here to return to the previous page |